Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about FERRITIN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | FERRITIN |
graph TD
FERRITIN["FERRITIN"]
FERRITIN -->|"binds"| Iron["Iron"]
FERRITIN -->|"involved_in"| IRON_METABOLISM["IRON METABOLISM"]
FERRITIN -->|"regulates"| Ischemia["Ischemia"]
FERRITIN -->|"regulates"| Als["Als"]
FERRITIN -->|"regulates"| Cancer["Cancer"]
FERRITIN -->|"regulates"| Ferroptosis["Ferroptosis"]
FERRITIN -->|"regulates"| Neurodegeneration["Neurodegeneration"]
NCOA4["NCOA4"] -->|"mediates"| FERRITIN
HFE["HFE"] -->|"regulates"| FERRITIN
TFR1["TFR1"] -->|"regulates"| FERRITIN
JUN["JUN"] -->|"regulates"| FERRITIN
MITOCHONDRIA["MITOCHONDRIA"] -->|"regulates"| FERRITIN
FERROPORTIN["FERROPORTIN"] -->|"regulates"| FERRITIN| Target | Relation | Type | Str |
|---|---|---|---|
| Iron | binds | compound | 0.95 |
| Tfr1 | binds | receptor | 0.90 |
| IRON METABOLISM | involved_in | entity | 0.90 |
| Iron Metabolism | involved_in | pathway | 0.88 |
| Ferroptosis | contributes_to | disease | 0.60 |
| Neurodegeneration | associated_with | disease | 0.60 |
| Parkinson | contributes_to | disease | 0.60 |
| Ischemia | inhibits | disease | 0.60 |
| Ferroptosis | therapeutic_target | disease | 0.60 |
| Aging | therapeutic_target | disease | 0.60 |
| Cancer | therapeutic_target | disease | 0.60 |
| Diabetes | inhibits | disease | 0.60 |
| Ferroptosis | inhibits | disease | 0.60 |
| Parkinson | activates | disease | 0.60 |
| Als | inhibits | disease | 0.60 |
| Parkinson | regulates | disease | 0.60 |
| Cancer | regulates | disease | 0.60 |
| Ferroptosis | regulates | disease | 0.60 |
| Ischemia | regulates | disease | 0.60 |
| Als | therapeutic_target | disease | 0.60 |
| Neurodegeneration | regulates | disease | 0.60 |
| Als | regulates | disease | 0.60 |
| Cardiomyopathy | inhibits | disease | 0.60 |
| Cancer | activates | disease | 0.60 |
| Ferroptosis | activates | disease | 0.60 |
| Autophagy | contributes_to | pathway | 0.55 |
| Oxidative Stress | activates | pathway | 0.55 |
| Blood-Brain Barrier | activates | pathway | 0.55 |
| Autophagy | degrades | pathway | 0.55 |
| Lipid Metabolism | inhibits | pathway | 0.55 |
| Autophagy | activates | pathway | 0.55 |
| Apoptosis | activates | pathway | 0.55 |
| Ferroptosis Pathway | therapeutic_target | pathway | 0.55 |
| Autophagy | regulates | pathway | 0.55 |
| Blood-Brain Barrier | therapeutic_target | pathway | 0.55 |
| Pi3K/Akt | regulates | pathway | 0.55 |
| Mtor | regulates | pathway | 0.55 |
| Mtor | activates | pathway | 0.55 |
| Pi3K/Akt | activates | pathway | 0.55 |
| Source | Relation | Type | Str |
|---|---|---|---|
| NCOA4 | degrades | gene | 0.90 |
| NCOA4 | mediates | gene | 0.90 |
| NCOA4 | degrades | entity | 0.90 |
| TXB2 | associated_with | drug | 0.70 |
| 6-OHDA | regulates | gene | 0.60 |
| DJ-1 | regulates | gene | 0.60 |
| PARKINSON | regulates | gene | 0.60 |
| FERROPTOSIS | inhibits | gene | 0.60 |
| GSH | inhibits | gene | 0.60 |
| LIPOPHAGY | regulates | gene | 0.60 |
| FERROPTOSIS | activates | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| AUTOPHAGY | activates | gene | 0.60 |
| FERROPTOSIS | therapeutic_target | gene | 0.60 |
| LIPOPHAGY | degrades | gene | 0.60 |
| AUTOPHAGY | contributes_to | gene | 0.60 |
| PARKINSON | activates | gene | 0.60 |
| HFE | regulates | gene | 0.60 |
| TFR1 | regulates | gene | 0.60 |
| JUN | regulates | gene | 0.60 |
| FERROPORTIN | regulates | gene | 0.60 |
| DMT1 | regulates | gene | 0.60 |
| GPX4 | regulates | gene | 0.60 |
| GPX4/SLC7A11 | regulates | gene | 0.60 |
| NCOA4 | activates | gene | 0.60 |
| SLC7A11 | regulates | gene | 0.60 |
| TFR1 | interacts_with | gene | 0.60 |
| GPX4 | inhibits | gene | 0.60 |
| VDR | inhibits | gene | 0.60 |
| MITOCHONDRIA | regulates | gene | 0.60 |
| SLC7A11 | inhibits | gene | 0.60 |
| ATG5 | activates | gene | 0.60 |
| BECN1 | regulates | gene | 0.60 |
| ATG13 | activates | gene | 0.60 |
| ATG3 | activates | gene | 0.60 |
| ATG4B | activates | gene | 0.60 |
| ATG7 | activates | gene | 0.60 |
| NOX1 | contributes_to | gene | 0.60 |
| IDH1 | regulates | gene | 0.60 |
| PRMT1 | regulates | gene | 0.60 |
| NCOA4 | regulates | gene | 0.60 |
| MTOR | regulates | gene | 0.60 |
| SCD1 | regulates | gene | 0.60 |
| NRF2 | regulates | gene | 0.60 |
| MTOR | activates | gene | 0.60 |
| AKT | activates | gene | 0.60 |
| PI3K | activates | gene | 0.60 |
| MAO | regulates | gene | 0.60 |
| ACETYL-COA | regulates | gene | 0.60 |
| RNA | regulates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| FUS-ALS-Specific Ferroptosis Vulnerability Through NCOA4-Med | 0.480 | - | Ferroptosis in ALS and motor neuron dise |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| S-equol-induced ferroptosis mechanism in TNBC cells | exploratory | Triple negative breast cancer | 0.900 | 0.00 | TNBC cell lines | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning FERRITIN in their description or question text
No additional research found